Marcelo Leonardo Nenkies

Factor X deficiency due to a compound heterozygosis between a new mutation (Gla72Asp) in exon 2 and an already known one (Gly154Arg) in exon 5: Factor X Mar del Plata 1).

S. Ferrari, A. Girolami, H. Guglielmone, 2018, Cardiovascular & hematological disorders drug targets.